Results published by Investigator on Image-guided Surgery in Penile Squamous Cell Carcinoma Patients

21 May 2021 | Collaborations, EMI-137

This pilot study suggest that c-MET is a promising target for fluorescence-guided tumour identification, with the potential to improve margin assessment in pSCC. The c-MET targeted approach proved to be compatible with lymphatic mapping performed in the same patient...

Results from Phase II clinical development of EMI-137 published

2 Oct 2020 | EMI-137

The work carried ou as part of Phase IIb stage of development of EMI-137 has showed FME using EMI-137 appeared to be safe andfeasible within a 1- to 3-h dose-to-imaging interval. No clinicallysignificant differences were observed among the cohorts, althougha 1-h...

Edinburgh Molecular Imaging Closes Financing

17 Dec 2019 | Press Releases

To accelerate evelopment of molecular targeted systemic radiotherapy (SR, PRRT) based on its clinical stage technology Edinburgh, United Kingdom – 17 December 2019 – Edinburgh Molecular Imaging Ltd, a company developing theragnostic agents targeting cancer, today...